Description of Symptoms Caused by the Infection of the SARS-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme: First Case Report From Santiago of Chile

Thumbnail Image

Files

487.pdf (997.22 KB)

Date

2022-03-21

Document type

journal article

Collections

Investigación
Total downloads20
Total views4
Bibliographic managers

Authors

Barrera-Avalos, Carlos, Luraschi, Roberto, Acuña-Castillo, Claudio, Vidal, Mabel, Mella-Torres, Andrea, Inostroza-Molina, Ailen, Vera, Rodrigo, Vargas, Sergio, Hernández, Iván, Perez, Christian, Vallejos-Vidal, Eva, Valdes, Daniel, Imarai, Monica, Reyes-López, Felipe E., Sandino, Ana Maria

Publisher

FRONTIERS MEDIA SA

URI

https://repositorio.udla.cl/handle/udla/1454

DOI

https://doi.org/10.3389/fpubh.2022.797569

Keywords

SARS-CoV-2 B, 1, 621 variant, genomic surveillance, inactivated SARS-CoV-2 vaccine, CoronaVac, case report, symptoms, COVID-19

Citation

Frontiers in Public Health, 10, 797569. https://doi.org/10.3389/fpubh.2022.797569

Abstract

Vaccine administration is one of the most efficient ways to control the current coronavirus disease 2019 (COVID-19) pandemic. However, the appearance of severe acute respiratory syndrome coronavirus 2...

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Creative Commons Attribution 4.0 International
Except where otherwised noted, this item's license is described as Creative Commons Attribution 4.0 International
Usage statistics
01345
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26